These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8107911)

  • 1. [Tumor markers in the screening, diagnosis and treatment of patients with breast carcinoma].
    van Dalen A
    Ned Tijdschr Geneeskd; 1994 Jan; 138(2):96-7. PubMed ID: 8107911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma].
    Thomas CM; Wobbes T; Bonfrer JM; Peterse JL; Nap M; Beex LV
    Ned Tijdschr Geneeskd; 1993 Nov; 137(46):2354-7. PubMed ID: 8264818
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L; Onetto M; Gardin G; Costanzi B; Giudici S; Vitiello E; Merlini L; Naso C; Zannini C; Paganuzzi M
    Cancer Detect Prev; 1993; 17(3):411-5. PubMed ID: 8402728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor markers in the diagnosis and therapy of intestinal neoplasms].
    Gräter H
    Schweiz Rundsch Med Prax; 1992 Jul; 81(31-32):943-4. PubMed ID: 1496207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor markers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements.
    Jäger W
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():133-9. PubMed ID: 8298443
    [No Abstract]   [Full Text] [Related]  

  • 8. Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction.
    Nekulová M; Simícková M; Pecen L; Eben K; Vermousek I; Stratil P; Cernoch M; Lang B
    Neoplasma; 1994; 41(2):113-8. PubMed ID: 8208314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can treatment response be measured in breast cancer patients?
    van Dalen A; van der Linde DL; Heering KJ; van Oudalblas AB
    Anticancer Res; 1993; 13(5C):1901-4. PubMed ID: 8267398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of tumor markers (among which carcinoembryonal antigen) in the diagnosis of malignant tumors in the gastrointestinal tract].
    Wobbes T; Thomas CM; Segers MF
    Ned Tijdschr Geneeskd; 1993 May; 137(20):995-9. PubMed ID: 7685066
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of four serological tumor markers for the detection of breast cancer.
    Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
    Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of tumor markers levels in determination of surgical procedure in patients with gallbladder carcinoma.
    Stefanović D; Novaković R; Perisić-Savić M; Djordjević Z; Zivanović M; Stajić S
    Med Pregl; 1993; 46 Suppl 1():58-9. PubMed ID: 8569609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinico-diagnostic significance of tumor markers in malignant neoplasms].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar' BN
    Voen Med Zh; 1993 Mar; (3):27-8. PubMed ID: 8498043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical usefulness of tumor markers in breast cancer].
    Konishi K; Karaki K; Watanabe K; Tsuda H; Konishi F
    Rinsho Byori; 1993 Oct; 41(10):1108-15. PubMed ID: 8254956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
    al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
    Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tumor markers on breast and ovarian cancer cell lines.
    Kämmerer U; Thanner F; Kapp M; Dietl J; Sütterlin M
    Anticancer Res; 2003; 23(2A):1051-5. PubMed ID: 12820346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.